4886 — ASKA Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00Brief: Dalton Investment Strongly Oppose Conditional Activation Of Countermeasures Announced By Aska Pharmaceutical Holdings On May 25
Brief: Aska Pharmaceutical -Plan To Put To Shareholders Proposal On Countermeasures Against Potential Large-Scale Share Purchase By Dalton And Related Parties
Table: Aska Pharmaceutical Holdings -2025/26 group results
Table: Aska Pharmaceutical Holdings -2025/26 group results
Insilico Medicine And Aska Pharmaceutical Expand Partnership To Discover Novel Targets For Women's Health
Table: Aska Pharmaceutical Holdings - 9-MTH group results
Table: Aska Pharmaceutical Holdings - 6-MTH group results
Table: Aska Pharmaceutical Holdings -Q1 group results
Brief: Aska Pharmaceutical: Dalton Notified Us It Is Withdrawing Plan For Large-Scale Purchase Of Aska Shares
Brief: Aska Pharmaceutical Holdings: Will Convey Concerns To Dalton, Urge To Fulfill Obligation To 'proactively' Provide Information In Accordance With Guidelines And Response Policy
Notice Concerning Request Made To Company Shareholders Daltone For Responses To Information List Pertaining To The Large-Scale Purchase
Brief: Japan's Aska Pharmaceutical Says U.S. Investment Fund Dalton Investments Notified Company About Possibility For Increasing Stake To Up To About 30%
Table: Aska Pharmaceutical Holdings -Q1 group results
Notice Concerning Introduction Of Response Policy To Large-Scale Purchase Etc. Of Company Share Certificates Etc. In Preparation For Large-Scale Purchase Etc. Of Company Share Certificates Etc. By Dalton Etc.
Notice Concerning Opinion Of Board Of Directors Of Company On Shareholder Proposal
Table: Aska Pharmaceutical Holdings -2024/25 group results
Brief: Nippon Active Value Fund And Related Parties Raise Stake In Aska Pharmaceutical To 19.43% From 17.94%, Regulatory Filing Shows
Company To Cancel 1.8 Million Treasury Shares On March 21
To Collaborate With Medchoice Pharma Inc Through Share Acquisition Of Fts Ambrose Holdings Inc